홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
Should Ticagrelor in association with aspirin be still considered the standard dual antiplatelet treatment for acute coronary syndromes? | Synapse
May 11, 2026
Should Ticagrelor in association with aspirin be still considered the standard dual antiplatelet treatment for acute coronary syndromes?
SS
Stefano De Servi
University of Pavia
CM
Claudio Montalto
Interventional Cardiology
SS
Stefano Savonitto
Martin University
Key Points
Key points are not available for this paper at this time.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Servi et al. (Fri,) studied this question.
synapsesocial.com/papers/6a025f0bc9581ed855361bd0
https://doi.org/https://doi.org/10.1016/j.ejim.2026.106918